Attractive stocks have exceptional fundamentals. In the case of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), there's is a company with strong financial health as well as a excellent growth outlook. Below is a brief commentary on these key aspects. For those interested in digging a bit deeper into my commentary, take a look at the report on Amphastar Pharmaceuticals here.
Excellent balance sheet with reasonable growth potential
Investors in search for stocks with room to flourish should look no further than AMPH, with its expected earinngs growth of 80%, supported by its outstanding capacity to churn out cash from operating activities, which is predicted to more than double over the next year. This indicates that earnings is driven by top-line activity rather than purely unsustainable cost-reduction initiatives. AMPH is financially robust, with ample cash on hand and short-term investments to meet upcoming liabilities. This indicates that AMPH has sufficient cash flows and proper cash management in place, which is an important determinant of the company’s health. AMPH's has produced operating cash levels of 0.54x total debt over the past year, which implies that AMPH's management has put its borrowings into good use by generating enough cash to cover a sufficient portion of borrowings.
For Amphastar Pharmaceuticals, I've compiled three essential aspects you should look at:
- Historical Performance: What has AMPH's returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
- Valuation: What is AMPH worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether AMPH is currently mispriced by the market.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of AMPH? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at firstname.lastname@example.org. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.